Advances in Immunology for Ocular Surface Diseases and Vitreoretinal Pathologies
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 2910
Special Issue Editor
Interests: ocular therapeutics; corneal neuropathy; dry eye disease; meibomian gland dysfunction; anterior segment morphology; corneal immunology; ocular surface neurobiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent studies have advanced ocular immunology, particularly in the context of diabetes, ocular allergies, uveitis, retinal disease, and dry eye disease. Despite these developments, there are still many unanswered questions in this growing field, highlighting the need for further research. This upcoming Issue will focus on the mechanisms and treatment of corneal neuroimmune abnormalities, specifically in metabolic diseases such as type 1 diabetes, diabetic chronic kidney disease, type 2 diabetes, metabolic syndrome, and prediabetes.
This Issue will examine how both diabetic and non-diabetic medications affect corneal neuroimmune features in conditions of impaired glycemia. Key areas of emphasis will include ocular allergies, dry eye disease, uveitis, and ischaemic retinopathy.
Additionally, the Issue will welcome original research papers and reviews concerning ocular surface inflammation and retinal inflammation in diabetes, age-related macular degeneration, and related complications
Dr. Kofi Asiedu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- corneal neuropathy
- diabetic keratopathy
- neuroimmune features
- neurotrophic keratitis
- dry eye disease in diabetes
- corneal neuroinflammation
- ocular surface disease
- diabetic retinopathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
